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Abstract
In this paper we present a multi-strain model for hepatitis C virus (HCV) including an immune response term. The
model is presented and discussed. Also we argue that the added multi-strain term represents some basic
properties of the immune system and that it should be included to study longer term behavior of the disease.
1. Introduction
Hepatitis C is one of many serious infectious diseases
affecting humans. An estimated about 170 million people
worldwide are infected with hepatitis C. No vaccine
against hepatitis C is available. Egypt has the highest rate
of infections by hepatitis C virus (HCV) genotype 4.
Chronic HCV infection is the main cause leading to liver
transplant or death [1]. Antiviral therapy has been used to
treat chronically HCV infected patients. Relatively success-
ful treatment contains pegylated interferon (PEG-IFN) and
ribavirin (RBV). Typical response ate biphasic beginning
with rapid viral decline phase followed by slower decline
phase. Sometimes there is more complicated behavior but
they will not be discussed here. Extensive and impressive
studies have been done by Perelson and his group [4-6].
Here we present a multi-strain generalization of a basic
HCV model [4] including the immune response (Ir) term
proposed in [3].
Why do we need mathematical models for HCV?
i) The ideal research group should contain both medical
doctors (MD) and mathematicians/and or biophysicists c.f.
Perelson group (Santa Fe).
ii) A standard result is that multi-drugs have to be used
for treatment. This does not seem to be the case for hepa-
titis C. Only Peg-IFN is used. Ribavirin (RBV) cannot be
considered as independent drug since, if used indepen-
dently, it has no effect on HCV.
iii) Multi-strain effects are relevant to HCV. Mathema-
tical models for multi-strain viruses can be quite useful.
In fact trying to anticipate the new strains experimen-
tally is quite difficult [7].
iv) Spatial effects of epidemics can be important. Typi-
cally they are difficult to quantify. Mathematical models
can help in this problem.
In sec.2 the model is presented and discussed. Also we
argue that the added immune response term represents
some basic properties of the immune system and that it
should be included to study longer term behavior of the
disease.
2. The model and conclusions
The fractional order hepatitis C virus (HCV) model is
given by
DαT = s− dT − (1− η)β V T,
DαI = (1− η)β V T − δ I(1− I/c2),
DαV = (1− εp)p I − c V,
(1)
Where 0 <a ≤ 1, T represents uninfected hepatocytes,
I represents infected hepatocytes and V represents virus.
The model assumes that uninfected hepatocytes are
produced at a constant rate s, die at rate, d, per cell and
are infected at constant rate b. Infected hepatocytes are
lost at a rate δ per cell. Viral particles (virions) are pro-
duced at rate p per infected hepatocyte and cleared at
rate c per virion. Chronic HCV infection is treated
using interferon-a in combination with the antiviral
drug ribavirin. Interferon-a acts primarily by blocking
the production/release of new virus, although we also
allow for a treatment effect in blocking de novo infec-
tion. The efficacy of treatment in blocking virion pro-
duction and reducing new infections are described by
two parameters, εp and h, respectively. For example, a
treatment efficacy in blocking virion production of 95%
corresponds to εp = 0.95.
Setting V to be proportional to I one gets the reduced
system:
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Where a, b, c, d, s are positive constants. There are
three equilibrium points of the system (2). The first is
the disease free (T =
s
d
, I = 0) and two endemic states
(T1, I1) and (T2, I2) where
Tj = b(1 -
Ij
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The locally asymptotic stability conditions for the two
endemic states are:
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d
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)Ij, j = 1,2. (6)
3. The multi-strain HC model
The model is given by:
DT = s - d T - a1I1T - a2I2T,
DI1 = a1I1T - b1I1(1 - I1/c1) + g1I2 .
DI2 = a2I2T - b2I2(1 - I2/c2) + g2I1,
(7)
where a1, a2, b1, b2, c1, c2, d, s, g1, g2 are positive
constants.
There are several equilibrium solutions: The disease
free state (T = s/d, I1 = I2 = 0). Four one strain endemic
states given by (T1j, I1j, 0) and (T2j, 0, I2j), j = 1, 2 and:
T1j = (b1/a1)(1 - I1j/c1),
I11 = { (1 - d/a1c1) + [(1 - d/a1c1)2 - (4/c1)(s/b1 - d/a1)](1/2)} c1/2,
I12 = { (1 - d/a1c1) - [(1 - d/a1c1)2 - (4/c1)(s/b1 - d/a1)](1/2)} c1/2,
T2j = (b2/a2)(1 - I2j/c2),
(8)
I21 = { (1 - d/a2c2) + [(1 - d/a2c2)2 - (4/c2)(s/b2 - d/a2)](1/2)} c2/2,
I22 = { (1 - d/a2c2) - [(1 - d/a2c2)2 - (4/c2)(s/b2 - d/a2)](1/2)} c2/2.
(9)
The multi-strain equilibrium solutions are given by
the system:
s - dT - a1I1T - a2I2T = 0,
a1I1T - b1I1(1 - I1/c1) + g1I2 = 0,
a2I2T - b2I2(1 - I2/c2) + g2I1 = 0.
(10)
The local asymptotic stability of the single healthy
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The local asymptotic stability of the one strain ende-
mic states are:
h1 > 0, h3 > 0, h1h2 > h3. (13)
For the state (T1j, I1j, 0) we have:
h1 = d + b1 + b2 + (a1 - 2b1/c1)I1j - (a1 + a2)T1j, (14)
h2 = −a1dT1j - g1g2 + b1(1 - 2I1j/c1)(d + a1I1j)+
( - a2T1j + b2)[d - a1T1j + b1 + (a1 - 2b1/c1)I1j],
(15)
and
h3 = ( - a2T1j + b2){ - a1dT1j + b1(1 - 2I1j/c1)(d + a1I1j)} +
g2[ - g1(d + a1I1j) + a1a2I1jT1j].
(16)
For the state (T2j, 0, I2j) we have:
h1 = d + b1 + b2 + (a2 - 2b2/c2)I2j - (a1 + a2)T2j, (17)
h2 = −a2dT2j - g1g2 + b2(1 - 2I2j/c2)(d + a2I2j)+
( - a1T2j + b1)[d - a2T2j + b2 + (a2 - 2b2/c2)I2j],
(18)
and
h3 = ( - a1T2j + b1){ - a2dT2j + b2(1 - 2I2j/c2)(d + a2I2j)} +
g1[ - g2(d + a2I2j) + a1a2I2jT2j].
(19)
We have the following conclusions:
i) Mathematical models, when done by a group of
mathematicians and HCV specialists give relevant
results [5].
ii) The term added in equation (1) represents the
well known high and low zone tolerance of the
immune response (There is no Ir if the antigen
number is either too high or too low [2]) since it
vanishes for both limits I ® 0 and I ® c2. Immune
response is significant for long time virus dynamics.
iii) Since multi-drugs are strongly recommended to
avoid drug resistance it is proposed that a further
drug should be used in addition to Peg-IFN and
RBV. Notice that RBV may not be considered as
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independent drug since, when used alone, it has no
effect on HCV.
iv Multi-strain phenomena is quite important. It
exists in many diseases e.g. Flu, HCV Tb etc... It
may cause the failure of treatment and/or vaccina-
tion protocols.
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